1. Home
  2. HRMY vs EVTC Comparison

HRMY vs EVTC Comparison

Compare HRMY & EVTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • EVTC
  • Stock Information
  • Founded
  • HRMY 2017
  • EVTC 1988
  • Country
  • HRMY United States
  • EVTC United States
  • Employees
  • HRMY N/A
  • EVTC N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • EVTC EDP Services
  • Sector
  • HRMY Health Care
  • EVTC Technology
  • Exchange
  • HRMY Nasdaq
  • EVTC Nasdaq
  • Market Cap
  • HRMY 2.2B
  • EVTC 2.0B
  • IPO Year
  • HRMY 2020
  • EVTC 2013
  • Fundamental
  • Price
  • HRMY $34.56
  • EVTC $33.19
  • Analyst Decision
  • HRMY Strong Buy
  • EVTC Hold
  • Analyst Count
  • HRMY 8
  • EVTC 3
  • Target Price
  • HRMY $54.38
  • EVTC $35.00
  • AVG Volume (30 Days)
  • HRMY 557.4K
  • EVTC 258.3K
  • Earning Date
  • HRMY 02-25-2025
  • EVTC 02-26-2025
  • Dividend Yield
  • HRMY N/A
  • EVTC 0.60%
  • EPS Growth
  • HRMY N/A
  • EVTC N/A
  • EPS
  • HRMY 2.11
  • EVTC 1.28
  • Revenue
  • HRMY $681,879,000.00
  • EVTC $823,712,000.00
  • Revenue This Year
  • HRMY $25.11
  • EVTC $23.87
  • Revenue Next Year
  • HRMY $19.19
  • EVTC $6.26
  • P/E Ratio
  • HRMY $16.46
  • EVTC $25.95
  • Revenue Growth
  • HRMY 25.83
  • EVTC 24.45
  • 52 Week Low
  • HRMY $28.14
  • EVTC $28.76
  • 52 Week High
  • HRMY $41.61
  • EVTC $41.57
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 35.54
  • EVTC 48.82
  • Support Level
  • HRMY $37.03
  • EVTC $32.49
  • Resistance Level
  • HRMY $39.91
  • EVTC $34.61
  • Average True Range (ATR)
  • HRMY 1.34
  • EVTC 0.62
  • MACD
  • HRMY -0.58
  • EVTC 0.12
  • Stochastic Oscillator
  • HRMY 9.86
  • EVTC 48.78

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely.

Share on Social Networks: